TAXparency - Understanding Tax Credits and Incentives for Biotech Startups hosted by LaunchBio
Name:
TAXparency - Understanding Tax Credits and Incentives for Biotech Startups hosted by LaunchBio
Date:
December 1, 2022
Time:
4:00 PM - 5:00 PM EST
Website:
Learn more and register!
Event Description:
Where do you start? Taxes often feel like a minefield with ever-changing rules and regulations, but it doesn’t have to always be that way.
For example, did you know that life science and biotech startups and their investors have several options for potential tax credits and incentives? Federal and state governments see the value of these companies, and tax incentives have been designed to encourage, support, and give opportunity to early stage companies and the investors who fund them.
In this webinar, entrepreneurs and investors will gain an understanding of the pros & cons of entity types, the ever-changing landscape concerning deductibility, tax implications of equity compensation (and balancing compliance with talent acquisition), tax credits and incentives, and how to take advantage of various credits and exemptions (R&D tax credits, R&D payroll credits, orphan drug credits, sales tax exemptions, angel investor credits, and the change in tax treatment for R&D).
Hundreds of companies and investors each year are taking advantage of these options, and with the help of our expert panel, you too may more clearly see your options and how to take full advantage of available opportunities.
Speakers:
Moderator:
• Tom Fagley - Partner, Hughes Pittman & Gupton, LLP
Panelists:
• Adam Buchanan - Partner, Hughes Pittman & Gupton, LLP
• TBA
For example, did you know that life science and biotech startups and their investors have several options for potential tax credits and incentives? Federal and state governments see the value of these companies, and tax incentives have been designed to encourage, support, and give opportunity to early stage companies and the investors who fund them.
In this webinar, entrepreneurs and investors will gain an understanding of the pros & cons of entity types, the ever-changing landscape concerning deductibility, tax implications of equity compensation (and balancing compliance with talent acquisition), tax credits and incentives, and how to take advantage of various credits and exemptions (R&D tax credits, R&D payroll credits, orphan drug credits, sales tax exemptions, angel investor credits, and the change in tax treatment for R&D).
Hundreds of companies and investors each year are taking advantage of these options, and with the help of our expert panel, you too may more clearly see your options and how to take full advantage of available opportunities.
Speakers:
Moderator:
• Tom Fagley - Partner, Hughes Pittman & Gupton, LLP
Panelists:
• Adam Buchanan - Partner, Hughes Pittman & Gupton, LLP
• TBA
